Vol. 30 No. 2 (2026)
CASE REPORTS

Valve-in-valve methodologies in transcatheter atrioventricular re-replacement using balloon-expandable prostheses: a series of clinical cases

PDF (Русский) PDF HTML (Русский) JATS XML (Русский)
  • Roman S. Tarasov,
  • Ivan V. Ganyukov,
  • Arina I. Danilovich,
  • Vladimir I. Ganyukov
Roman S. Tarasov
Research Institute for Complex Issues of Cardiovascular Diseases
Ivan V. Ganyukov
Research Institute for Complex Issues of Cardiovascular Diseases
Arina I. Danilovich
Research Institute for Complex Issues of Cardiovascular Diseases
Bio
Vladimir I. Ganyukov
Research Institute for Complex Issues of Cardiovascular Diseases
DOI: https://doi.org/10.21688/1681-3472-2026-2-67-76

Published 2026-08-10

Keywords

  • balloon-expandable prosthesis; bioprosthesis dysfunction; mitral valve; transcatheter valve replacement using the “valve-in-valve” method; tricuspid valve

How to Cite

Tarasov, R. S. ., Ganyukov, I. V. ., Danilovich, A. I. ., & Ganyukov, V. I. . (2026). Valve-in-valve methodologies in transcatheter atrioventricular re-replacement using balloon-expandable prostheses: a series of clinical cases. Patologiya Krovoobrashcheniya I Kardiokhirurgiya, 30(2), 67–76. https://doi.org/10.21688/1681-3472-2026-2-67-76

Copyright (c) 2026 Tarasov et al.

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Abstract

Introduction: Given the annual increase in the need for repeated heart valve replacement, which is a high-risk surgical procedure due to repeated surgical access against the background of severe adhesions, trauma and comorbidity of patients, the technique of transcatheter heart valve replacement is becoming increasingly relevant and preferable.

Objective: To present in detail modern methodologies for transcatheter mitral and tricuspid valve replacement using clinical examples.

Methods: The presented patients had dysfunction of a previously openly implanted mitral/tricuspid bioprosthesis according to clinical data and echocardiography. Taking into account the high risk of surgical intervention, resternotomy and comorbid condition, after analyzing multispiral computed tomography within the framework of the cardiac team (cardiologist, endovascular surgeon, cardiovascular surgeon) it was decided to perform endovascular transcatheter repeat replacement using the "valve-in-valve" method. In both cases, puncture vascular access through the common femoral vein was used.

Results: Balloon-expandable heart valve prostheses were effectively implanted in patients in the atrioventricular positions, achieving satisfactory hemodynamic parameters. Local anesthesia and transthoracic echocardiography were used for transcatheter tricuspid valve replacement. Mitral valve replacement was performed under total intravenous anesthesia, artificial ventilation, using transesophageal echocardiography, ultra-frequent cardiac pacing, and puncture of the interatrial septum. No complications were detected in the intra- and postoperative periods. The patients were discharged on the seventh day after the intervention.

Conclusion: The methodology of transcatheter atrioventricular heart valve replacement is presented using clinical cases as an example, the effectiveness and safety of endovascular mitral and tricuspid valve replacement using balloon-expandable prostheses are shown. Further studies are needed that can provide a comparative assessment of the technologies of transcatheter and surgical atrioventricular heart valve replacement based on the analysis of long-term surgical results.

Received 29 April 2025. Revised 28 January 2026. Accepted 3 February 2026.

Informed consent

The patient's informed consent to use the records for medical purposes is obtained.

Funding

The study was carried out with financial support from the Ministry of Science and Higher Education of the Russian Federation as part of the research project "Endovascular and extracorporeal technologies for the prevention and treatment of structural heart pathology and critical conditions in cardiac surgery" (No. 0419-2026-0004).

Conflict of interest

The authors declare no conflict of interest.

Contribution of the authors

Conception and study design: R.S. Tarasov, V.I. Ganyukov

Data collection and analysis: I.V. Ganyukov, A.I. Danilovich

Statistical analysis: I.V. Ganyukov, A.I. Danilovich

Drafting the article: I.V. Ganyukov

Critical revision of the article: R.S. Tarasov, V.I. Ganyukov

Final approval of the version to be published: all authors

PDF (Русский) PDF HTML (Русский) JATS XML (Русский)

References

  1. Panaich S.S., Eleid M.F. Tricuspid valve-in-valve implantation for failing bioprosthetic valves: an evolving standard of care. Ann Transl Med. 2016;4(20):410. PMID: 27867962; PMCID: PMC5107395. https://doi.org/10.21037/atm.2016.10.44
  2. Глушкова Т.В., Костюнин А.Е. Структура кальцификатов в биопротезах клапанов сердца, консервированных диглицидиловым эфиром этиленгликоля. Комплексные проблемы сердечно-сосудистых заболеваний. 2021;10(2):16-24. https://doi.org/10.17802/2306-1278-2021-10-2-16-24 Glushkova T.V., Kostyunin A.E. Calcification of bioprosthetic heart valves treated with ethylene glycol diglycidyl ether. Complex Issues of Cardiovascular Diseases. 2021;10(2):16-24. (In Russ.) https://doi.org/10.17802/2306-1278-2021-10-2-16-24
  3. Morimoto N., Matsushima S., Aoki M., Henmi S., Nishioka N., Murakami H., Honda T., Nakagiri K., Yoshida M., Mukohara N. Long-term results of bioprosthetic tricuspid valve replacement: an analysis of 25 years of experience. Gen Thorac Cardiovasc Surg. 2013;61(3):133-8. PMID: 23224685. https://doi.org/10.1007/s11748-012-0190-4
  4. Thourani V.H., Bonnell L., Wyler von Ballmoos M.C., Mehaffey J.H., Bowdish M., Kurlansky P., Jacobs J.P., O'Brien S., Shahian D.M., Badhwar V. Outcomes of Isolated Tricuspid Valve Surgery: A Society of Thoracic Surgeons Analysis and Risk Model. Ann Thorac Surg. 2024;118(4):873-881. PMID: 38723881. https://doi.org/10.1016/j.athoracsur.2024.04.014
  5. Bourguignon T., Bouquiaux-Stablo A.L., Loardi C., Mirza A., Candolfi P., Marchand M., Aupart M.R. Very late outcomes for mitral valve replacement with the Carpentier-Edwards pericardial bioprosthesis: 25-year follow-up of 450 implantations. J Thorac Cardiovasc Surg. 2014;148(5):2004-2011.e1. PMID: 24667021. https://doi.org/10.1016/j.jtcvs.2014.02.050
  6. Vaijyanath P., Thangavelu S.V. Structural Challenges in Native Atrioventricular Valves Replacement. Cardiol Clin. 2024;42(3):403-415. PMID: 38910024. https://doi.org/10.1016/j.ccl.2024.04.001
  7. Vahanian A., Beyersdorf F., Praz F., Milojevic M., Baldus S., Bauersachs J., Capodanno D., Conradi L., De Bonis M., De Paulis R., Delgado V., Freemantle N., Gilard M., Haugaa K.H., Jeppsson A., Juni P., Pierard L., Prendergast B.D., Sadaba J.R., Tribouilloy C., Wojakowski W.; ESC/EACTS Scientific Document Group. 2021 ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J. 2022;43(7):561-632. PMID: 34453165. https://doi.org/10.1093/eurheartj/ehab395
  8. Pibarot P., Herrmann H.C., Wu C., Hahn R.T., Otto C.M., Abbas A.E., Chambers J., Dweck M.R., Leipsic J.A., Simonato M., Rogers T., Sathananthan J., Guerrero M., Ternacle J., Wijeysundera H.C., Sondergaard L., Barbanti M., Salaun E., Généreux P., Kaneko T., Landes U., Wood D.A., Deeb G.M., Sellers S.L., Lewis J., Madhavan M., Gillam L., Reardon M., Bleiziffer S., O'Gara P.T., Rodés-Cabau J., Grayburn P.A., Lancellotti P., Thourani V.H., Bax J.J., Mack M.J., Leon M.B.; Heart Valve Collaboratory. Standardized Definitions for Bioprosthetic Valve Dysfunction Following Aortic or Mitral Valve Replacement: JACC State-of-the-Art Review. J Am Coll Cardiol. 2022;80(5):545-561. PMID: 35902178. https://doi.org/10.1016/j.jacc.2022.06.002
  9. Marin-Cuartas M., de Waha S., Saeed D., Misfeld M., Kiefer P., Borger M.A. Considerations for Reoperative Heart Valve Surgery. Struct Heart. 2022;7(1):100098. PMID: 37275309; PMCID: PMC10236806. https://doi.org/10.1016/j.shj.2022.100098